An experimental study of the anticonvulsant effect of amlodipine in mice

K. N. Sathyanarayana Rao, N. K. Subbalakshmi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: The need for the rational development of newer and adjuvant drugs to treat epilepsy has prompted this study of the potential anticonvulsant effect of amlodipine. Methods: The acute effect was studied in mice in single doses of 1 mg/kg, 2 mg/kg and 4 mg/kg of amlodipine and the chronic effect was studied in doses of 1 mg/kg and 4 mg/kg (administered daily for 21 days) using the maximal electroshock seizure and pentylenetetrazole-induced seizure models of epilepsy. Sodium valproate and normal saline were used as the standard and control, respectively. Results: For the acute study, in the maximal electroshock seizure model, the administration of 1 mg/kg of amlodipine resulted in the complete abolition of seizures in 33 percent of the mice, and this was increased to 67 percent with the administration of 4 mg/kg. In the pentylenetetrazole-induced seizure model, the administration of 1 mg/kg and 2 mg/kg amlodipine protected 33 percent of the animals from mortality, and 67 percent were protected with the administration of 4 mg/kg. For the chronic study, in the maximal electroshock seizure model, the administration of 1 mg/kg amlodipine resulted in the complete abolition of seizures in 40 percent of the mice and in 60 percent, with the administration of 4 mg/kg. In the pentylenetetrazole-induced seizure model, 50 percent of the mice were protected from mortality with 1 mg/kg amlodipine and 60 percent, with 4 mg/kg amlodipine. Conclusion: These f indings indicate that amlodipine may be a good candidate as an add-on therapy for epilepsy.

Original languageEnglish
Pages (from-to)424-428
Number of pages5
JournalSingapore Medical Journal
Volume51
Issue number5
Publication statusPublished - 01-05-2010
Externally publishedYes

Fingerprint

Amlodipine
Anticonvulsants
Seizures
Electroshock
Pentylenetetrazole
Epilepsy
Mortality
Valproic Acid

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Sathyanarayana Rao, K. N., & Subbalakshmi, N. K. (2010). An experimental study of the anticonvulsant effect of amlodipine in mice. Singapore Medical Journal, 51(5), 424-428.
Sathyanarayana Rao, K. N. ; Subbalakshmi, N. K. / An experimental study of the anticonvulsant effect of amlodipine in mice. In: Singapore Medical Journal. 2010 ; Vol. 51, No. 5. pp. 424-428.
@article{4aeec7b4f6564448ae69300483822e15,
title = "An experimental study of the anticonvulsant effect of amlodipine in mice",
abstract = "Introduction: The need for the rational development of newer and adjuvant drugs to treat epilepsy has prompted this study of the potential anticonvulsant effect of amlodipine. Methods: The acute effect was studied in mice in single doses of 1 mg/kg, 2 mg/kg and 4 mg/kg of amlodipine and the chronic effect was studied in doses of 1 mg/kg and 4 mg/kg (administered daily for 21 days) using the maximal electroshock seizure and pentylenetetrazole-induced seizure models of epilepsy. Sodium valproate and normal saline were used as the standard and control, respectively. Results: For the acute study, in the maximal electroshock seizure model, the administration of 1 mg/kg of amlodipine resulted in the complete abolition of seizures in 33 percent of the mice, and this was increased to 67 percent with the administration of 4 mg/kg. In the pentylenetetrazole-induced seizure model, the administration of 1 mg/kg and 2 mg/kg amlodipine protected 33 percent of the animals from mortality, and 67 percent were protected with the administration of 4 mg/kg. For the chronic study, in the maximal electroshock seizure model, the administration of 1 mg/kg amlodipine resulted in the complete abolition of seizures in 40 percent of the mice and in 60 percent, with the administration of 4 mg/kg. In the pentylenetetrazole-induced seizure model, 50 percent of the mice were protected from mortality with 1 mg/kg amlodipine and 60 percent, with 4 mg/kg amlodipine. Conclusion: These f indings indicate that amlodipine may be a good candidate as an add-on therapy for epilepsy.",
author = "{Sathyanarayana Rao}, {K. N.} and Subbalakshmi, {N. K.}",
year = "2010",
month = "5",
day = "1",
language = "English",
volume = "51",
pages = "424--428",
journal = "Singapore Medical Journal",
issn = "0037-5675",
publisher = "Singapore Medical Association",
number = "5",

}

Sathyanarayana Rao, KN & Subbalakshmi, NK 2010, 'An experimental study of the anticonvulsant effect of amlodipine in mice', Singapore Medical Journal, vol. 51, no. 5, pp. 424-428.

An experimental study of the anticonvulsant effect of amlodipine in mice. / Sathyanarayana Rao, K. N.; Subbalakshmi, N. K.

In: Singapore Medical Journal, Vol. 51, No. 5, 01.05.2010, p. 424-428.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An experimental study of the anticonvulsant effect of amlodipine in mice

AU - Sathyanarayana Rao, K. N.

AU - Subbalakshmi, N. K.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Introduction: The need for the rational development of newer and adjuvant drugs to treat epilepsy has prompted this study of the potential anticonvulsant effect of amlodipine. Methods: The acute effect was studied in mice in single doses of 1 mg/kg, 2 mg/kg and 4 mg/kg of amlodipine and the chronic effect was studied in doses of 1 mg/kg and 4 mg/kg (administered daily for 21 days) using the maximal electroshock seizure and pentylenetetrazole-induced seizure models of epilepsy. Sodium valproate and normal saline were used as the standard and control, respectively. Results: For the acute study, in the maximal electroshock seizure model, the administration of 1 mg/kg of amlodipine resulted in the complete abolition of seizures in 33 percent of the mice, and this was increased to 67 percent with the administration of 4 mg/kg. In the pentylenetetrazole-induced seizure model, the administration of 1 mg/kg and 2 mg/kg amlodipine protected 33 percent of the animals from mortality, and 67 percent were protected with the administration of 4 mg/kg. For the chronic study, in the maximal electroshock seizure model, the administration of 1 mg/kg amlodipine resulted in the complete abolition of seizures in 40 percent of the mice and in 60 percent, with the administration of 4 mg/kg. In the pentylenetetrazole-induced seizure model, 50 percent of the mice were protected from mortality with 1 mg/kg amlodipine and 60 percent, with 4 mg/kg amlodipine. Conclusion: These f indings indicate that amlodipine may be a good candidate as an add-on therapy for epilepsy.

AB - Introduction: The need for the rational development of newer and adjuvant drugs to treat epilepsy has prompted this study of the potential anticonvulsant effect of amlodipine. Methods: The acute effect was studied in mice in single doses of 1 mg/kg, 2 mg/kg and 4 mg/kg of amlodipine and the chronic effect was studied in doses of 1 mg/kg and 4 mg/kg (administered daily for 21 days) using the maximal electroshock seizure and pentylenetetrazole-induced seizure models of epilepsy. Sodium valproate and normal saline were used as the standard and control, respectively. Results: For the acute study, in the maximal electroshock seizure model, the administration of 1 mg/kg of amlodipine resulted in the complete abolition of seizures in 33 percent of the mice, and this was increased to 67 percent with the administration of 4 mg/kg. In the pentylenetetrazole-induced seizure model, the administration of 1 mg/kg and 2 mg/kg amlodipine protected 33 percent of the animals from mortality, and 67 percent were protected with the administration of 4 mg/kg. For the chronic study, in the maximal electroshock seizure model, the administration of 1 mg/kg amlodipine resulted in the complete abolition of seizures in 40 percent of the mice and in 60 percent, with the administration of 4 mg/kg. In the pentylenetetrazole-induced seizure model, 50 percent of the mice were protected from mortality with 1 mg/kg amlodipine and 60 percent, with 4 mg/kg amlodipine. Conclusion: These f indings indicate that amlodipine may be a good candidate as an add-on therapy for epilepsy.

UR - http://www.scopus.com/inward/record.url?scp=79951501115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951501115&partnerID=8YFLogxK

M3 - Article

C2 - 20593148

AN - SCOPUS:79951501115

VL - 51

SP - 424

EP - 428

JO - Singapore Medical Journal

JF - Singapore Medical Journal

SN - 0037-5675

IS - 5

ER -

Sathyanarayana Rao KN, Subbalakshmi NK. An experimental study of the anticonvulsant effect of amlodipine in mice. Singapore Medical Journal. 2010 May 1;51(5):424-428.